Article
Evaluations of rationally designed rift valley fever vaccine candidate RVax-1 in mosquito and rodent models
21 Sept 2022
Abstract excerpt
Rift Valley fever (RVF) is a mosquito-borne zoonosis endemic to Africa and the Arabian Peninsula, which causes large outbreaks among humans and ruminants. Single dose vaccinations using live-attenuated RVF virus (RVFV) support effective prevention of viral spread in endemic countries. Due to the segmented nature of RVFV genomic RNA, segments of vaccine strain-derived genomic RNA could be incorporated into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
